ARMP

3.0301.68%
PK

Pierre Kyme

Chief Business Officer

Dr. Pierre Kyme, Ph.D., is Chief Business Officer at Armata Pharmaceuticals, Inc. since June 2024 and had been its Senior Vice President of Business and Corporate Development since 2024 until June 2024 and was its Vice President of Business & Corporate Development from July 2023 until 2024. Previously, Dr. Kyme served as Director of Product Development at C3J Therapeutics from 2012, leading a team that set strategy and delivered key data essential for advancing a lead antimicrobial molecule through Phase 2 human clinical trials. He also contributed to the company’s pipeline programs, providing medical and commercial rationale to justify pipeline expansion. Prior to this, he spent 5 years maturing his drug development career at Cedars-Sinai Medical Center leading project teams from concept through preclinical research in infectious disease and immunology. In this capacity, he worked closely with the Technology Transfer Office and was the recipient of the Malaniak Award for Excellence in Research. Prior to this, in Partnership with Qiagen Pty. Ltd. Dr. Kyme worked at Sydney's Millennium Institute, as part of a priority national grant for urgent research into avian influenza. Dr. Kyme has also served as Scientific Advisor for the Australia Desk and Life Sciences & Healthcare Practice at Cappello Global, a boutique investment bank and as consultant Analyst to a global specialist life sciences investment firm, evaluating multiple therapeutic areas. His work contributed to capital raising for a private U. S. oncology biotech, which in 2012 initiated the world's largest Phase 3 human clinical trial for a melanoma vaccine. He completed his postdoctoral training at the Michael Smith Laboratories in Vancouver, Canada, from the Gates Foundation Grand Challenges in Global Health initiative, developing Innate Defense Regulators in Partnership with Inimex Pharmaceuticals (acquired by Soligenix). Dr. Kyme earned his Ph. D. in Medicine from the University of Sydney, Australia, the bulk of which was accomplished as an invited scholar at the University of Tübingen, Germany.

Positions